Immunoscore predicts significant differences in time to recurrence in stage I colon cancer patients

J. Galon; F. Hermitte; B. Mlecnik; F. Marliot; C. Bifulco; A. Lugli; I. Nagtegaal; A. Hartmann; M. van den Eynde; M. Roehrl; P. Ohashi; E. Zavadova; T. Torigoe; P. Patel; Y. Wang; Y. Kawakami; F. Marincola; P. Ascierto; B. Fox; F. Pagès

doi:10.1093/ANNONC/MDZ421

Immunoscore predicts significant differences in time to recurrence in stage I colon cancer patients

J. Galon
, F. Hermitte
, B. Mlecnik
, F. Marliot
, C. Bifulco
, A. Lugli
, I. Nagtegaal
, A. Hartmann
, M. van den Eynde
, M. Roehrl
, P. Ohashi
, E. Zavadova
, T. Torigoe
, P. Patel
, Y. Wang
, Y. Kawakami
, F. Marincola
, P. Ascierto
, B. Fox
, F. Pagès

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Annals of Oncology
Volume	30
DOIs	https://doi.org/10.1093/ANNONC/MDZ421
State	Published - Nov 1 2019

Disciplines

Medicine and Health Sciences
Multivariate Analysis
Internal Medicine

Access to Document

10.1093/ANNONC/MDZ421License: Unspecified

Cite this

Galon, J., Hermitte, F., Mlecnik, B., Marliot, F., Bifulco, C., Lugli, A., Nagtegaal, I., Hartmann, A., van den Eynde, M., Roehrl, M., Ohashi, P., Zavadova, E., Torigoe, T., Patel, P., Wang, Y., Kawakami, Y., Marincola, F., Ascierto, P., Fox, B., & Pagès, F. (2019). Immunoscore predicts significant differences in time to recurrence in stage I colon cancer patients. Annals of Oncology, 30. https://doi.org/10.1093/ANNONC/MDZ421

@article{f8f9b431a7844a5cb26787a96e116b34,

title = "Immunoscore predicts significant differences in time to recurrence in stage I colon cancer patients",

author = "J. Galon and F. Hermitte and B. Mlecnik and F. Marliot and C. Bifulco and A. Lugli and I. Nagtegaal and A. Hartmann and \{van den Eynde\}, M. and M. Roehrl and P. Ohashi and E. Zavadova and T. Torigoe and P. Patel and Y. Wang and Y. Kawakami and F. Marincola and P. Ascierto and B. Fox and F. Pag{\`e}s",

note = "Immunoscore{\textregistered} is an in vitro diagnostic test that predicts the risk of relapse in patients with Colon Cancer (CC) by measuring the host immune response at the tumor site. It is an immune risk-assessment tool providing independent and superior prognostic value than traditional histopathological risk parameters, and is intended to be used as an adjunct to the TNM classification.",

year = "2019",

month = nov,

day = "1",

doi = "10.1093/ANNONC/MDZ421",

language = "American English",

volume = "30",

journal = "Annals of Oncology",

}

Galon, J, Hermitte, F, Mlecnik, B, Marliot, F, Bifulco, C, Lugli, A, Nagtegaal, I, Hartmann, A, van den Eynde, M, Roehrl, M, Ohashi, P, Zavadova, E, Torigoe, T, Patel, P, Wang, Y, Kawakami, Y, Marincola, F, Ascierto, P, Fox, B & Pagès, F 2019, 'Immunoscore predicts significant differences in time to recurrence in stage I colon cancer patients', Annals of Oncology, vol. 30. https://doi.org/10.1093/ANNONC/MDZ421

TY - JOUR

T1 - Immunoscore predicts significant differences in time to recurrence in stage I colon cancer patients

AU - Galon, J.

AU - Hermitte, F.

AU - Mlecnik, B.

AU - Marliot, F.

AU - Bifulco, C.

AU - Lugli, A.

AU - Nagtegaal, I.

AU - Hartmann, A.

AU - van den Eynde, M.

AU - Roehrl, M.

AU - Ohashi, P.

AU - Zavadova, E.

AU - Torigoe, T.

AU - Patel, P.

AU - Wang, Y.

AU - Kawakami, Y.

AU - Marincola, F.

AU - Ascierto, P.

AU - Fox, B.

AU - Pagès, F.

N1 - Immunoscore® is an in vitro diagnostic test that predicts the risk of relapse in patients with Colon Cancer (CC) by measuring the host immune response at the tumor site. It is an immune risk-assessment tool providing independent and superior prognostic value than traditional histopathological risk parameters, and is intended to be used as an adjunct to the TNM classification.

PY - 2019/11/1

Y1 - 2019/11/1

UR - https://www.annalsofoncology.org/article/S0923-7534(19)57799-7/fulltext

U2 - 10.1093/ANNONC/MDZ421

DO - 10.1093/ANNONC/MDZ421

M3 - Article

VL - 30

JO - Annals of Oncology

JF - Annals of Oncology

ER -

Immunoscore predicts significant differences in time to recurrence in stage I colon cancer patients

Disciplines

Access to Document

Other files and links

Cite this